CHD2 and cancer: ACTL6A, CHD2, and ACTB had the highest pan‐cancer G‐score for amplification, whereas CHD5, SHPRH, INO80, and ACTR8 had the highest pan‐cancer G‐score for deletions (Figure S1A and Table S3).